ADC Bio developing downstream bioconjugation process
ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that...
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious...
Inovio, Parker Institute for Cancer Immunotherapy enter clinical collaboration to evaluate new cancer immunotherapy...
Inovio Pharmaceuticals, Inc. and the Parker Institute for Cancer Immunotherapy have entered into a clinical...
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
STORM Therapeutics, the leading drug discovery company focused on small molecule therapies modulating RNA modifying...
Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca
Myriad Genetics, Inc. , a leader in molecular diagnostics and personalized medicine, announced that AstraZeneca...
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a...
Idorsia forms research collaboration with Roche in the field of cancer immunotherapy
Idorsia Ltd announced that it has entered into a research collaboration that provides Roche with...
NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug
NorthSea Therapeutics B.V. , a newly established Dutch biotech company, announced the completion of a...
Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit...
Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and Institute Curie in...
Torque Launches Platform to Develop New Class of Deep Primed Immune Cell Therapies
Torque, an immuno-oncology company developing Deep Primed cell therapies that direct and evoke immune responses...